Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Income from Continuing Operations (2023 - 2025)

Nuvation Bio (NUVB) has disclosed Income from Continuing Operations for 3 consecutive years, with 36592000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations rose 25.99% to 36592000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 204627000.0, a 63.97% increase, with the full-year FY2025 number at 204627000.0, up 63.97% from a year prior.
  • Income from Continuing Operations was 36592000.0 for Q4 2025 at Nuvation Bio, up from 55792000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 13787000.0 in Q4 2023 to a low of 462492000.0 in Q2 2024.
  • A 3-year average of 70697333.33 and a median of 38901000.0 in 2024 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: tumbled 2140.76% in 2024, then skyrocketed 87.24% in 2025.
  • Nuvation Bio's Income from Continuing Operations stood at 13787000.0 in 2023, then plummeted by 258.63% to 49445000.0 in 2024, then grew by 25.99% to 36592000.0 in 2025.
  • Per Business Quant, the three most recent readings for NUVB's Income from Continuing Operations are 36592000.0 (Q4 2025), 55792000.0 (Q3 2025), and 59007000.0 (Q2 2025).